Chronic kidney disease in disadvantaged populations

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Martins, David ^a   Agodoa, Lawrence ^b   Norris, Keith ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866163031     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/469265     Document Type: Review

References (39)

1. Coresh J., Selvin E., Stevens L. A., Manzi J., Kusek J. W., Eggers P., Van Lente F., Levey A. S., Prevalence of chronic kidney disease in the United States. Journal of the American Medical Association 2007 298 17 2038 2047 2-s2.0-35848968871 10.1001/jama.298.17.2038 (Pubitemid 350074801)
2. Chen J., Wildman R. P., Gu D., Kusek J. W., Spruill M., Reynolds K., Liu D., Hamm L. L., Whelton P. K., He J., Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney International 2005 68 6 2837 2845 2-s2.0-32844457422 10.1111/j.1523-1755.2005.00757.x (Pubitemid 43251031)
3. Chadban S. J., Briganti E. M., Kerr P. G., Dunstan D. W., Welborn T. A., Zimmet P. Z., Atkins R. C., Prevalence of kidney damage in Australian adults: The AusDiab kidney study. Journal of the American Society of Nephrology 2003 14 2 S131 S138 2-s2.0-0037530393 (Pubitemid 36750508)
4. Viktorsdottir O., Palsson R., Andresdottir M. B., Aspelund T., Gudnason V., Indridason O. S., Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrology Dialysis Transplantation 2005 20 9 1799 1807 2-s2.0-24044533238 10.1093/ndt/gfh914 (Pubitemid 41222591)
5. Otero A., Gayoso P., Garcia F., de Francisco A. L., Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney international. Supplement. 2005 99 S16 S19 2-s2.0-33644975610
6. Cirillo M., Laurenzi M., Mancini M., Zanchetti A., Lombardi C., De Santo N. G., Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney International 2006 70 4 800 806 2-s2.0-33747041339 10.1038/sj.ki.5001641 (Pubitemid 44215358)
7. Levey A. S., Coresh J., Bolton K., Culleton B., Harvey K. S., Ikizler T. A., Johnson C. A., Kausz A., Kimmel P. L., Kusek J., Levin A., Minaker K. L., Nelson R., Rennke H., Steffes M., Witten B., Hogg R. J., Furth S., Lemley K. V., Portman R. J., Schwartz G., Lau J., Balk E., Perrone R. D., Karim T., Rayan L., Al-Massry I., Chew P., Astor B. C., De Vine D., Eknoyan G., Levin N., Burrows-Hudson S., Keane W., Kliger A., Latos D., Mapes D., Oberley E., Willis K., Bailie G., Becker G., Burrowes J., Churchill D., Collins A., Couser W., DeZeeuw D., Garber A., Golper T., Gotch F., Gotto A., Greer J. W., Grimm Jr. R., Hannah R. G., Acosta J. H., Hogg R., Hunsicker L., Klag M., Klahr S., Lewis C., Lowrie E., Matas A., McCulloch S., Michael M., Nally J. V., Newmann J. M., Nissenson A., Norris K., Owen Jr. W., Patel T. G., Payne G., Rivera-Mizzoni R. A., Smith D., Star R., Steinman T., Valderrabano F., Walls J., Wauters J. -P., Wenger N., Briggs J., K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002 39 2, supplement 1 S1 S266
8. Hallan S. I., Coresh J., Astor B. C., Åsberg A., Powe N. R., Romundstad S., Hallan H. A., Lydersen S., Holmen J., International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. Journal of the American Society of Nephrology 2006 17 8 2275 2284 2-s2.0-33746508501 10.1681/ASN.2005121273 (Pubitemid 44141918)
9. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
10. Correa-Rotter R., González-Michaca L., Early detection and prevention of diabetic nephropathy: a challenge calling for mandatory action for Mexico and the developing world. Kidney International, Supplement 2005 68 98 S69 S75 2-s2.0-33644594763 10.1111/j.1523-1755.2005.09813.x
11. Cusumano A. M., Garcia G. G., Di Gioia C., Hermida O., Lavorato C., The Latin American dialysis and transplantation registry (RLDT) annual report 2004. Ethnicity and Disease 2006 16 S2 10 13 2-s2.0-33746034979
12. Shaheen F. A. M., Al-Khader A. A., Preventive strategies of renal failure in the Arab world. Kidney International, Supplement 2005 68 98 S37 S40 2-s2.0-33644596537 10.1111/j.1523-1755.2005.09807.x
13. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
14. United States Renal Data System (USRDS) 2000 Annual Data.
15. Barsoum R. S., End-stage renal disease in North Africa. Kidney International, Supplement 2003 63 83 S111 S114 2-s2.0-0037249334 (Pubitemid 36126855)
16. Kher V., Madias N. E., Harrington J. T., Chugh K. S., Shah B., Jones R., Dutta A. R., Ballal H. S., Sundar S., Lloyd V., Pereira B., Jha V., Rajapurkar M., Kohli H., Singhal M., End-stage renal disease in developing countries. Kidney International 2002 62 1 350 362 2-s2.0-0036314865 10.1046/j.1523-1755. 2002.00426.x (Pubitemid 34754084)
17. US Renal Data System, USRDS 2010 annual data report: atlas of end-stage renal disease in the United States 2010 Bethesda, Md, USA National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease
18. Norris K. C., Agodoa L. Y., Unraveling the racial disparities associated with kidney disease. Kidney International 2005 68 3 914 924 2-s2.0-32644464443 10.1111/j.1523-1755.2005.00485.x (Pubitemid 43246408)
19. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S. M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., Hong Y., Heart disease and stroke statistics-2008 Update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2008 117 4 e25 e46 2-s2.0-39749191084 10.1161/CIRCULATIONAHA.107.187998
20. Turner R., Holman R., Stratton I., Cull C., Frighi V., Manley S., Matthews D., Neil A., McElroy H., Kohner E., Fox C., Hadden D., Wright D., Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1998 317 7160 703 713 (Pubitemid 28414300)
21. Egan B. M., Zhao Y., Axon R. N., US trends in prevalence, awareness, treatment, and control of hypertension, 19882008. Journal of the American Medical Association 2010 303 20 2043 2050 2-s2.0-77952750659 10.1001/jama.2010.650
22. McAlister F. A., finlay.mcalister@ualberta.ca Wilkins K., Joffres M., Leenen F. H. H., Fodor G., Gee M., Tremblay M. S., Walker R., Johansen H., Campbell N., Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011 183 9 1007 1013 10.1503/cmaj.101767
23. Kao W. H. L., Klag M. J., Meoni L. A., Reich D., Berthier-Schaad Y., Li M., Coresh J., Patterson N., Tandon A., Powe N. R., Fink N. E., Sadler J. H., Weir M. R., Abboud H. E., Adler S. G., Divers J., Iyengar S. K., Freedman B. I., Kimmel P. L., Knowler W. C., Kohn O. F., Kramp K., Leehey D. J., Nicholas S. B., Pahl M. V., Schelling J. R., Sedor J. R., Thornley-Brown D., Winkler C. A., Smith M. W., Parekh R. S., MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nature Genetics 2008 40 10 1185 1192 2-s2.0-52949092735 10.1038/ng.232
24. Genovese G., Friedman D. J., Ross M. D., Lecordier L., Uzureau P., Freedman B. I., Bowden D. W., Langefeld C. D., Oleksyk T. K., Uscinski Knob A. L., Bernhardy A. J., Hicks P. J., Nelson G. W., Vanhollebeke B., Winkler C. A., Kopp J. B., Pays E., Pollak M. R., Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010 329 5993 841 845 2-s2.0-77955646179 10.1126/science.1193032
25. Freedman B. I., Kopp J. B., Langefeld C. D., Genovese G., Friedman D. J., Nelson G. W., Winkler C. A., Bowden D. W., Pollak M. R., The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. Journal of the American Society of Nephrology 2010 21 9 1422 1426 2-s2.0-77956535289 10.1681/ASN.2010070730
26. Materson B. J., Reda D. J., Cushman W. C., Massie B. M., Freis E. D., Kochar M. S., Hamburger R. J., Fye C., Lakshman R., Gottdiener J., Ramirez E. A., Henderson W. G., Single-drug therapy for hypertension in mena comparison of six antihypertensive agents with placebo. New England Journal of Medicine 1993 328 13 914 921. Erratum in: New England Journal of Medicine, vol. 330, no. 23, p. 1689, 1994 10.1056/NEJM199304013281303 (Pubitemid 23086643)
27. Norris K. C., Tareen N., Martins D., Vaziri N. D., Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans. Nature Clinical Practice Nephrology 2008 4 10 538 549 2-s2.0-52949085446 10.1038/ncpneph0909
28. de Jong P. E., van der Velde M., Gansevoort R. T., Zoccali C., Screening for chronic kidney disease: where does Europe go? Clinical Journal of the American Society of Nephrology 2008 3 2 616 623 2-s2.0-42549122959 10.2215/CJN.04381007
29. Knight E. L., Kramer H. M., Curhan G. C., High-normal blood pressure and microalbuminuria. American Journal of Kidney Diseases 2003 41 3 588 595 2-s2.0-0037373851 10.1053/ajkd.2003.50120 (Pubitemid 36278376)
30. Norris K. C., Agodoa L. Y., Unraveling the racial disparities associated with kidney disease. Kidney International 2005 68 3 914 924 2-s2.0-32644464443 10.1111/j.1523-1755.2005.00485.x (Pubitemid 43246408)
31. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
32. Baigent C., Burbury K., Wheeler D., Premature cardiovascular disease in chronic renal failure. Lancet 2000 356 9224 147 152 2-s2.0-0034622282 (Pubitemid 30438520)
33. Luft F. C., Grim C. E., Fineberg N., Weinberger M. C., Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 1979 59 4 643 650 2-s2.0-0018340682 (Pubitemid 9154955)
34. Chandramohan G., Bai Y., Norris K., Rodriguez-Iturbe B., Vaziri N. D., Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF- κ B activity in salt-sensitive and -resistant rat kidneys. American Journal of Nephrology 2007 28 1 158 167 2-s2.0-36248967155 10.1159/000110021 (Pubitemid 350126507)
35. Hayakawa H., Coffee K., Raij L., Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 1997 96 7 2407 2413 2-s2.0-0030798337
36. Wright J. T. Jr., Bakris G., Greene T., Agodoa L. Y., Appel L. J., Charleston J., Cheek D., Douglas-Baltimore J. G., Gassman J., Glassock R., Hebert L., Jamerson K., Lewis J., Phillips R. A., Toto R. D., Middleton J. P., Rostand S. G., Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Journal of the American Medical Association 2002 288 19 2421 2431. Erratum in: Journal of the American Medical Association, vol. 295, no. 23, p. 2726, 2006 10.1001/jama.288.19.2421 (Pubitemid 35340538)
37. Appel L. J., lappel@jhmi.edu Wright J. T. Jr., Greene T., Agodoa L. Y., Astor B. C., Bakris G. L., Cleveland W. H., Charleston J., Contreras G., Faulkner M. L., Gabbai F. B., Gassman J. J., Hebert L. A., Jamerson K. A., Kopple J. D., Kusek J. W., Lash J. P., Lea J. P., Lewis J. B., Lipkowitz M. S., Massry S. G., Miller E. R., Norris K., Phillips R. A., Pogue V. A., Randall O. S., Rostand S. G., Smogorzewski M. J., Toto R. D., Wang X., Intensive blood-pressure control in hypertensive chronic kidney disease. New England Journal of Medicine 2010 363 10 918 929 10.1056/NEJMoa0910975
38. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Executive summary. American Journal of Kidney Diseases 2004 42 supplement 1 16 33
39. Lea J., Greene T., Hebert L., Lipkowitz M., Massry S., Middleton J., Rostand S. G., Miller E., Smith W., Bakris G. L., The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Archives of Internal Medicine 2005 165 8 947 953 2-s2.0-20244382844 10.1001/archinte.165.8. 947 (Pubitemid 40563243)